BOT — Botanix Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$32.81m
- AU$8.12m
- AU$33.80m
Australia Stock Exchange release from BOTANIX PHARMACE : Investor Presentation - Annual General meeting
Australia Stock Exchange release from BOTANIX PHARMACE : Appendix 4C - Quarterly
Australia Stock Exchange release from BOTANIX PHARMACE : PRE_NR Ends: 09:47:19
Australia Stock Exchange release from BOTANIX PHARMACE : Notification regarding unquoted securities - BOT
Australia's Botanix jumps on starting trials to test canine eczema drug
Australia Stock Exchange release from BOTANIX PHARMACE : PRE_NR Ends: 09:36:31
Australia Stock Exchange release from BOTANIX PHARMACE : Canine Atopic Dermatitis Program Launched
Australia Stock Exchange release from BOTANIX : Botanix Expands Management Team
Australia Stock Exchange release from BOTANIX : Letter to Shareholders - Annual General Meeting
Australia Stock Exchange release from BOTANIX : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from BOTANIX : Botanix Presentation Corporate Update
Australia Stock Exchange release from BOTANIX : Final Report and Annual Report to Shareholders
Australia Stock Exchange release from BOTANIX : PRE_NR Ends: 09:43:43
Australia Stock Exchange release from BOTANIX : Apendix 4G
Australia Stock Exchange release from BOTANIX : Annual General Meeting
Australia Stock Exchange release from BOTANIX : New Canine Pilot Study Supports Further AD Investigation
Australia Stock Exchange release from BOTANIX : PRE_NR Ends: 09:06:25
Australia Stock Exchange release from BOTANIX : Updated Investor Presentation and Conference Call
Australia Stock Exchange release from BOTANIX : Botanix Update on BTX 1801 Clinical Development